ANNEX ISupplementary provisions
ANNEX I
‘B. Purity characteristics
Category
Fatty acid composition
( 1 )
Total transoleic isomers
(%)
Total trans- linoleic + trans-linolenic isomers
(%)
Stigmasta- dienes
(mg/kg)
( 2 )
ΔΕCN42
2-glyceryl monopalmitate
(%)
Myristic
(%)
Linolenic
(%)
Arachidic
(%)
Eicosenoic
(%)
Behenic
(%)
Lignoceric
(%)
1.
Extra virgin olive oil
≤ 0,03
≤ 1,00 ( 3 )
≤ 0,60
≤ 0,50
≤ 0,20
≤ 0,20
≤ 0,05
≤ 0,05
≤ 0,05
≤ |0,20 |
≤ 0,9 if total palmitic acid % ≤ 14,00 %
≤ 1,0 if total palmitic acid % > 14,00 %
2.
Virgin olive oil
≤ 0,03
≤ 1,00 ( 3 )
≤ 0,60
≤ 0,50
≤ 0,20
≤ 0,20
≤ 0,05
≤ 0,05
≤ 0,05
≤ |0,20 |
≤ 0,9 if total palmitic acid % ≤ 14,00 %
≤ 1,0 if total palmitic acid % > 14,00 %
3.
Lampante olive oil
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,20
≤ 0,20
≤ 0,10
≤ 0,10
≤ 0,50
≤ |0,30 |
≤ 0,9 if total palmitic acid % ≤ 14,00 %
≤ 1,1 if total palmitic acid % > 14,00 %
4.
Refined olive oil
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,20
≤ 0,20
≤ 0,20
≤ 0,30
—
≤ |0,30 |
≤ 0,9 if total palmitic acid % ≤ 14,00 %
≤ 1,1 if total palmitic acid% > 14,00 %
5.
Olive oil composed of refined olive oil and virgin olive oils
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,20
≤ 0,20
≤ 0,20
≤ 0,30
—
≤ |0,30 |
≤ 0,9 if total palmitic acid% ≤ 14,00 %
≤ 1,0 if total palmitic acid% > 14,00 %
6.
Crude olive-pomace oil
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,30
≤ 0,20
≤ 0,20
≤ 0,10
—
≤ |0,60 |
≤ 1,4
7.
Refined olive-pomace oil
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,30
≤ 0,20
≤ 0,40
≤ 0,35
—
≤ |0,50 |
≤ 1,4
8.
Olive-pomace oil
≤ 0,03
≤ 1,00
≤ 0,60
≤ 0,50
≤ 0,30
≤ 0,20
≤ 0,40
≤ 0,35
—
≤ |0,50 |
≤ 1,2
Table B continued
Category
Sterols composition
Total sterols
(mg/kg)
Erythrodiol and uvaol (**) (%)
Waxes (**) (mg/kg)
Chole-sterol (%)
Brassica-sterol (%)
Campe-sterol(%)
Stigmasterol (%)
Apparent β–sito-sterol
( 4 )
(%)
Δ-7-stigma-stenol (%)
1.
Extra virgin olive oil
≤ 0,5
≤ 0,1
≤ 4,0 ( 5 )
< Camp.
≥ 93,0
≤ 0,5 ( 6 )
≥ 1 000
≤ 4,5
C42 + C44 + C46 ≤ 150
2.
Virgin olive oil
≤ 0,5
≤ 0,1
≤ 4,0 ( 5 )
< Camp.
≥ 93,0
≤ 0,5 ( 6 )
≥ 1 000
≤ 4,5
C42 + C44 + C46 ≤ 150
3.
Lampante olive oil
≤ 0,5
≤ 0,1
≤ 4,0
—
≥ 93,0
≤ 0,5 ( 7 )
≥ 1 000
≤ 4,5 ( 8 )
C40 + C42 + C44 + C46 ≤ 300 ( 8 )
4.
Refined olive oil
≤ 0,5
≤ 0,1
≤ 4,0
< Camp.
≥ 93,0
≤ 0,5 ( 9 )
≥ 1 000
≤ 4,5 ( 10 )
C40 + C42 + C44 + C46 ≤ 350
5.
Olive oil composed of refined olive oil and virgin olive oils
≤ 0,5
≤ 0,1
≤ 4,0
< Camp.
≥ 93,0
≤ 0,5 ( 9 )
≥ 1 000
≤ 4,5
C40 + C42 + C44 + C46 ≤ 350
6.
Crude olive-pomace oil
≤ 0,5
≤ 0,2
≤ 4,0
—
≥ 93,0
≤ 0,5 ( 11 )
≥ 2 500
> 4,5 ( 12 )
C40 + C42 + C44 + C46 > 350 ( 12 )
7.
Refined olive-pomace oil
≤ 0,5
≤ 0,2
≤ 4,0
< Camp.
≥ 93,0
≤ 0,5 ( 11 )
≥ 1 800
> 4,5
C40 + C42 + C44 + C46 > 350
8.
Olive-pomace oil
≤ 0,5
≤ 0,2
≤ 4,0
< Camp.
≥ 93,0
≤ 0,5 ( 11 )
≥ 1 600
> 4,5
C40 + C42 + C44 + C46 > 350
Notes:
(a)
The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4.
(b)
If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation.
(c)
For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category.
(d)
If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’
( 1 ) Other fatty acids content (%): palmitic: 7,00-20,00; palmitoleic: 0,30-3,50; heptadecanoic: ≤ 0,40; heptadecenoic ≤ 0,60; stearic: 0,50-5,00; oleic: 55,00-85,00; linoleic: 2,50-21,00.
( 2 ) Total isomers which could (or could not) be separated by capillary column.
( 3 ) When the linolenic acid is more than 1,00 but less than or equal 1,40, the ratio apparent β-sitosterol/campesterol has to be greater than or equal to 24.
( 4 ) Apparent β-sitosterol: Δ-5,23-stigmastadienol+clerosterol+ β-sitosterol+sitostanol+ Δ-5-avenasterol+ Δ-5,24-stigmastadienol.
( 5 ) An extra virgin or virgin olive oil that exhibits 4,0 < campesterol % ≤ 4,5 is authentic provided that stigmasterol ≤ 1,4 %, Δ-7-stigmastenol ≤ 0,3 % and all other parameters lie within the limits fixed in this Regulation.
( 6 ) An extra virgin or virgin olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔECN42 ≤|0,10| and all other parameters lie within the limits fixed in this Regulation.
( 7 ) A lampante olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15|, stigmastadienes ≤ 0,30 mg/kg and all other parameters lie within the limits fixed in this Regulation.
( 8 ) Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be lampante olive oil if the total aliphatic alcohol content is less than or equal to 350 mg/kg or if the erythrodiol and uvaol content is less than or equal to 3,5 %.
( 9 ) A refined olive oil or olive oil composed of refined olive oil and virgin olive oils that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15| and all other parameters lie within the limits fixed in this Regulation.
( 10 ) Oils with an erythrodiol + uvaol content of between 4,5 and 6 % must have an erythrodiol content of less than or equal to 75 mg/kg.
( 11 ) A crude olive-pomace oil or refined olive-pomace oil or olive-pomace oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that stigmasterol ≤ 1,4 %, ΔECN42 ≤ |0,40| and all other parameters lie within the limits fixed in this Regulation.
( 12 ) Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be crude olive-pomace oil if the total aliphatic alcohol content is above 350 mg/kg and if the erythrodiol and uvaol content is greater than 3,5 %.
ANNEX IISupplementary provisions
ANNEX II
‘ANNEX III
CORRELATION TABLE
Implementing Regulation (EU) No 29/2012
Regulation (EEC) No 2568/91
This Regulation
Implementing Regulation (EU) 2022/2105
—
—
Article 1, point (a)
—
—
Article 1
—
—
Article 2(2)
Article 1(1)
Article 1, point (b), and Article 1(2)
Article 1(2)
Article 1, point (b)
Article 2, first paragraph
Article 4(1)
Article 2, second paragraph
Article 4(2)
Article 3, first paragraph
Article 6(1)
Article 3, second paragraph, points (a) to (d)
Article 6(2), points (a) to (d)
Article 4(1), first subparagraph
Article 8(1)
Article 4(1), second subparagraph
Article 8(2)
Article 4(1), third subparagraph
—
Article 4(2)
Article 8(3)
Article 4(3)
Article 8(4)
Article 4(4)
Article 8(5)
Article 4(5), first subparagraph
Article 8(6)
Article 4(5), second subparagraph
Article 8(7)
Article 4a
Article 7
Article 4b
Article 5
Article 5, first paragraph, points (a) to (d)
Article 10, points (a) to (d)
Article 5, first paragraph, point (e)
Article 11(1) and (2)
Article 5, second paragraph
—
Article 5a, first paragraph
Article 11(3)
Article 5a, second paragraph
Article 11(4)
Article 5a, third paragraph
Article 11(5)
Article 6(1), first subparagraph
Article 12(1)
Article 6(1), second subparagraph
Article 12(2)
Article 6(1), third subparagraph
Article 3(3)
Article 6(2), first subparagraph
Article 12(3)
Article 6(2), second subparagraph
Article 12(4)
Article 6(3)
Article 12(5)
—
—
Article 12(6)
Article 6(4)
—
Article 7
Article 5(2)
Article 8(1)
Article 2(3)
Article 8(2)
Article 4(3)
Article 8(3)
Article 4(2)
Article 8(4)
Article 4(3)
Article 8a
Article 2(1) and Article 4(1)
Article 9(1), first subparagraph
Article 13(1)
Article 9(1), second subparagraph
Article 13(2)
Article 9(1), third subparagraph
—
Article 9(1), fourth subparagraph
—
Article 9(1), fifth subparagraph
—
Article 9(2),first subparagraph
Article 6(1)
Article 9(2), second subparagraph, points (a), (b) and (c)
Article 6(2), points (a), (b) and (c)
Article 9(2), third subparagraph
Article 9
—
Article 6(3)
Article 10, first paragraph, introductory sentence
Article 14
Article 10, first paragraph, points (a) to (d), and second paragraph
—
Article 10a
Article 14
Annex I
—
Annex II
—
Article 1(1)
Article 2(1), points (a) and (b)
Article 1(2)
Article 2(1), point (c)
Article 1(3)
Article 2(1), point (d)
Article 1(4)
Article 2(1), point (e)
Article 1(5)
Article 2(1), point (f)
Article 1(6)
Article 2(1), point (g)
Article 1(7)
Article 2(1), point (h)
—
—
Article 2(2)
—
—
Article 3(1) and (2)
Article 2(1)
Article 7
Article 2(1), point (a)
Annex I, point 1
Article 2(1), point (b)
Annex I, point 2
Article 2(1), point (c)
—
Article 2(1), point (d)
—
Article 2(1), point (e)
Annex I, point 3
Article 2(1), point (f)
Annex I, point 4
Article 2(1), point (g)
Annex I, point 6
Article 2(1), point (h)
—
Article 2(1), point (i)
Annex I, point 5
Article 2(1), point (j)
Annex I, point 9
Article 2(1), point (k)
Annex I, point 10
Article 2(1), point (l)
Annex I, point 8
Article 2(1), point (m)
Annex I, point 7
Article 2(2), first subparagraph and part of point 9.4 of Annex XII
Article 10(1)
Article 2(2), second subparagraph
Article 11(1)
Article 2(2), third subparagraph
Article 11(2)
—
Article 11(3)
part of point 9.4 of Annex XII
Article 11(4)
Article 2(3), first subparagraph
Article 3(1)
Article 2(3), second subparagraph
Article 3(2)
Article 2(4), first subparagraph
Article 9(2)
Article 2(4), second subparagraph
Article 9(3)
Article 2(4), third subparagraph
Article 9(4)
Article 2(5)
Article 9(5)
Article 2a(1)
Article 3(1)
Article 2a(2)
Article 3(3)
Article 2a(3)
Article 3(4)
Article 2a(4), first subparagraph
Article 3(5)
Article 2a(4), second subparagraph
Article 3(2)
Article 2a(5)
Article 9(1)
Article 3, first paragraph
Article 13(1)
Article 3, second paragraph
Article 3(6)
Article 4(1), first subparagraph
Article 10(1)
Article 4(1), second subparagraph
Article 10(2)
Article 4(1), third subparagraph
Article 10(3)
Article 4(2)
Article 10(4)
Article 4(3)
-
Article 6(1)
Article 12(1)
Article 6(2)
Article 12(2)
Article 7
—
Article 7a, first subparagraph
Article 5(1)
Article 7a, second paragraph
Article 2(2)
Article 8(1)
—
Article 8(2)
Article 14
Annex I
Annex I
Annex XII, point 3.3
Annex II
Annex Ia, except for point 2.1
Annex II
Annex Ia, point 2.1
Article 9(6)
Annex Ib
Annex III
Annex III
—
Annex IV
—
Annex VII
—
Annex IX
—
Annex X
—
Annex XI
—
Annex XII, except for point 3.3 and part of point 9.4
—
Annex XV
Annex IV
Annex XVI
—
Annex XVII
—
Annex XVIII
—
Annex XIX
—
Annex XX
—
Annex XXI
Annex V
’